Company intelligence / Profile preview
GRDG Sciences
Winter Haven, Florida, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
GRDG Sciences has achieved major milestones in developing universal therapeutic drug platforms, obtaining a valuation exceeding $500M following its initial cancer and infectious disease research phase, but has not yet advanced to clinical trials.
- Therapeutic areas
- OncologyInfectious DiseasesNeurology
- Modalities
- Small moleculePossibly Biologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Destum Partners
Beyond the preview
Go deeper on GRDG Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GRDG Sciences.